Our new cardiometabolic care solution, Verily Lightpath, will help members meet and maintain cardiometabolic health goals through access to an AI helper, designed to inform personal pathways, monitor behavior, and support engagement.* *To be available for open enrollment in early 2026
The most potential for AI in healthcare is in improving, not replacing, what physicians can do for a patient, says Andrew Trister, MD PhD, our Chief Medical and Scientific Officer. By taking longitudinal data that is incorporated from a patient’s health record and sources like wearable devices, AI can be applied to gain insight for faster treatment. Dr. Trister will be speaking in depth about AI’s potential to inform the learning health system at American Society of Clinical Oncology (ASCO) Breakthrough on August 8. Get a preview of his keynote.
Happy National Intern Day to our interns! They join us from University of Waterloo, University of Windsor, University of California, Berkeley, University of Illinois Urbana-Champaign and Harvard Business School to learn and contribute to Verily’s purpose of bringing precision health to everyone, every day. We are thrilled to have these future leaders be a part of hashtag#LifeAtVerily this summer ☀️
Today, Verily is changing our corporate headquarters from South San Francisco, CA to Dallas, Texas. Since opening our Dallas office three years ago, Verily has become an active leader in the growing DFW healthcare and tech ecosystem. The area offers a growing talent pool in health and technology and provides a central US office location for Verily to bridge our east and west coast locations – where we continue to invest and grow our presence in the SF Bay Area, Boston, Greater Toronto and Raleigh. As the industry and regional population grow in Dallas, we look forward to our continued contributions as an economic player and community leader in the years ahead. We’re hiring! Check out our openings.
Verily Lightpath Metabolic programs* for health plans will be a smart, dynamic and personalized approach to help manage diabetes, obesity, hypertension and more. Explore the AI-powered metabolic care offerings, backed by deep clinical expertise. *To be available for open enrollment in early 2026
The Verily team recently attended AHIP 2024, the leading industry conference for health insurance plans. Verily leaders weighed in on the challenges health plans face and the tech solutions designed to drive more personalized care. Here are the top 3 highlights from the show floor: 1️⃣ Dr. Vindell Washington on health equity: “One of the guiding product inclusion principles is that health equity doesn’t sit to the side of the solution.” 2️⃣ Yes, AI-powered care can be effective, but it relies on high-quality data and regulatory safety measures. 3️⃣ GLP-1s and virtual programs must combine to create real value. Verily also announced its launch of Verily Lightpath Metabolic, an AI-powered precision virtual care solution to be available for open enrollment beginning in January 2026.
When wastewater data showed an uncharacteristic spike in influenza A, Verily scientists, in partnership with WastewaterSCAN, developed an H5 assay to help trace the highly pathogenic H5N1 virus infection. We’re currently testing for H5 at more than a hundred wastewater sites in over 40 states across the country. Read more in Bloomberg about Verily’s wastewater program and our work with the Centers for Disease Control and Prevention.
One of the goals of our LGBTv employee resource group (ERG) is to foster a community where members feel supported, safe and that they belong. Throughout the year the ERG hosts social events and gathers to talk about important issues surrounding health and representation. This year for hashtag#PrideMonth the LGBTv ERG wanted to expand beyond Verily and continue building community among members and allies by getting together with fellow Alphabet companies, Waymo and X, the moonshot factory, to celebrate Pride.
We are proud to partner with Aligning Science Across Parkinson’s | ASAP on the newly launched ASAP CRN Cloud, a groundbreaking data-sharing platform available to the entire Parkinson’s Disease research community. Created in collaboration with The Michael J. Fox Foundation for Parkinson's Research, DNAstack and DataTecnica LLC, the tool includes a unique dataset of human postmortem-derived brain samples for analysis. ASAP CRN Cloud uses Verily Viewpoint Workbench, a collaborative environment where scientists worldwide can securely access, analyze and share multimodal Parkinson’s data, in order to advance understanding of the disease and accelerate research.
In a recent study, researchers from Verily and Google Research compared pre-translation with direct inference of large language models (LLMs) on multilingual tasks. They showed that direct inference can be more efficient and effective in multilingual settings, alleviating the limitations of pre-translation.
